StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx cash

Cash and short-term investments held at the end of each period.

BioCorRx's cash was $21.24K at Jun 30, 2026. For fiscal 2025 it was $139.36K, up 58.3% from the year before. Over ten years it grew -4.5% a year on average. The highest annual figure on record is $2.65M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$139.36K+58.3%
FY2024Dec 31, 2024$88.03K+35.0%
FY2023Dec 31, 2023$65.22K-4.9%
FY2022Dec 31, 2022$68.62K-20.1%
FY2021Dec 31, 2021$85.84K-85.5%
FY2020Dec 31, 2020$592.05K-77.6%
FY2019Dec 31, 2019$2.65M+845.7%
FY2018Dec 31, 2018$279.77K+2366.7%
FY2017Dec 31, 2017$11.34K-87.7%
FY2016Dec 31, 2016$92.46K-58.0%
FY2015Dec 31, 2015$220.06K+314.3%
FY2014Dec 31, 2014$53.12K-51.1%
FY2013Dec 31, 2013$108.57K+1708.8%
FY2012Dec 31, 2012$6.00K+262.2%
FY2011Dec 31, 2011$1.66K-76.8%
FY2010Dec 31, 2010$7.13K-74.5%
FY2009Dec 31, 2009$27.92K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$21.24K-81.0%
Q1 FY2026Mar 31, 2026$211.91K+777.8%
Q4 FY2025Dec 31, 2025$139.36K+58.3%
Q3 FY2025Sep 30, 2025$287.69K+319553.3%
Q2 FY2025Jun 30, 2025$111.87K+1237.4%
Q1 FY2025Mar 31, 2025$24.14K-76.1%
Q4 FY2024Dec 31, 2024$88.03K+35.0%
Q3 FY2024Sep 30, 2024$90-99.9%
Q2 FY2024Jun 30, 2024$8.37K-95.8%
Q1 FY2024Mar 31, 2024$101.08K-50.4%
Q4 FY2023Dec 31, 2023$65.22K-4.9%
Q3 FY2023Sep 30, 2023$156.41K+142.3%
Q2 FY2023Jun 30, 2023$197.30K+129.9%
Q1 FY2023Mar 31, 2023$203.69K-72.7%
Q4 FY2022Dec 31, 2022$68.62K-96.4%
Q1 FY2022Mar 31, 2022$64.55K-89.1%
Q4 FY2021Dec 31, 2021$85.84K-90.8%
Q2 FY2021Sep 30, 2021$745.46K-49.1%
Q1 FY2021Mar 31, 2021$1.91M-3.1%
Q4 FY2020Dec 31, 2020$592.05K-77.6%
Q3 FY2020Sep 30, 2020$936.21K-73.9%
Q2 FY2020Jun 30, 2020$1.46M-69.6%
Q1 FY2020Mar 31, 2020$1.97M+10391.6%
Q4 FY2019Dec 31, 2019$2.65M+845.7%
Q3 FY2019Sep 30, 2019$3.59M+1363.1%
Q2 FY2019Jun 30, 2019$4.81M+734.1%
Q1 FY2019Mar 31, 2019$18.79K+939.6%
Q4 FY2018Dec 31, 2018$279.77K+2366.7%
Q3 FY2018Sep 30, 2018$245.37K-13.5%
Q2 FY2018Jun 30, 2018$577.01K-31.7%
Q1 FY2018Mar 31, 2018$1.81K-99.9%
Q4 FY2017Dec 31, 2017$11.34K-87.7%
Q3 FY2017Sep 30, 2017$283.54K+251.7%
Q2 FY2017Jun 30, 2017$845.07K-28.1%
Q1 FY2017Mar 31, 2017$1.68M+1282.8%
Q4 FY2016Dec 31, 2016$92.46K-58.0%
Q3 FY2016Sep 30, 2016$80.63K–
Q2 FY2016Jun 30, 2016$1.17M–
Q1 FY2016Mar 31, 2016$121.67K–
Q4 FY2015Dec 31, 2015$220.06K–

More BioCorRx figures

See a number that looks wrong?